Page last updated: 2024-10-24

carbamazepine epoxide and Neural Tube Defects

carbamazepine epoxide has been researched along with Neural Tube Defects in 1 studies

carbamazepine epoxide: metabolite of carbamazepine; RN given refers to unlabeled cpd
carbamazepine-10,11-epoxide : An epoxide and metabolite of carbamazepine.

Neural Tube Defects: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy generally occurring between days 18-29 of gestation. Ectodermal and mesodermal malformations (mainly involving the skull and vertebrae) may occur as a result of defects of neural tube closure. (From Joynt, Clinical Neurology, 1992, Ch55, pp31-41)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koren, G1

Other Studies

1 other study available for carbamazepine epoxide and Neural Tube Defects

ArticleYear
Comment on antiepileptics and antipsychotics.
    Teratology, 2002, Volume: 66, Issue:6

    Topics: Animals; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Female; Folic Acid; Hematinics; Human

2002